Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Drug DiscoveryCRO

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1753419

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1753419

Catheters and Active Implantable CDMO

PUBLISHED:
PAGES: 277 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Catheters and Active Implantable CDMO Market to Reach US$18.8 Billion by 2030

The global market for Catheters and Active Implantable CDMO estimated at US$10.4 Billion in the year 2024, is expected to reach US$18.8 Billion by 2030, growing at a CAGR of 10.5% over the analysis period 2024-2030. Catheters, one of the segments analyzed in the report, is expected to record a 12.0% CAGR and reach US$7.8 Billion by the end of the analysis period. Growth in the Active Implantable Devices segment is estimated at 9.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.8 Billion While China is Forecast to Grow at 14.5% CAGR

The Catheters and Active Implantable CDMO market in the U.S. is estimated at US$2.8 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.9 Billion by the year 2030 trailing a CAGR of 14.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.4% and 9.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.3% CAGR.

Global "Catheters and Active Implantable CDMO" Market - Key Trends & Drivers Summarized

Why Is There a Surge in Demand for CDMO Services in Catheters and Active Implantables?

The market for catheters and active implantable devices has seen a significant uptick, propelled by a fusion of complex patient demands and rapidly evolving medical technologies. At the heart of this trend lies the growing reliance on Contract Development and Manufacturing Organizations (CDMOs) to deliver highly specialized solutions across cardiovascular, neurovascular, urology, and electrophysiology applications. As medical device OEMs (Original Equipment Manufacturers) face mounting regulatory hurdles and the need for faster time-to-market, CDMOs have emerged as vital strategic partners. These specialized firms bring in-depth expertise in regulatory compliance, precision engineering, and clinical-grade manufacturing, enabling OEMs to focus on core R&D and commercialization. In catheter development, CDMOs are increasingly being tasked with managing everything from raw material selection and extrusion to final sterilization and packaging. The growing complexity of active implantables-such as cardiac rhythm management devices, neurostimulators, and infusion pumps-requires multidomain knowledge in microelectronics, software integration, and biocompatible materials, all of which high-end CDMOs are well-equipped to handle.

How Are Technological Innovations Transforming Product Development Pipelines?

Cutting-edge technological integration is radically reshaping the CDMO landscape for catheters and active implantables. Innovations in material science-such as the use of ultra-thin polymers, hydrophilic coatings, and bioresorbable composites-are enabling the development of catheters that are safer, more comfortable, and more functional. Similarly, in the active implantables domain, miniaturization and power efficiency are guiding principles driving next-gen devices. CDMOs are at the forefront of incorporating wireless telemetry, rechargeable batteries, and software-controlled functionalities in implantable devices. Additionally, 3D printing is being increasingly adopted for prototyping complex catheter tip geometries and housings for implantables. The convergence of IoT (Internet of Things) and MedTech is also redefining expectations, with smart catheters capable of real-time data transmission and implantables that can self-monitor and adjust therapy parameters. CDMOs with robust electronics integration and software validation capabilities are becoming indispensable partners in this innovation-driven ecosystem. Their ability to scale manufacturing of such high-precision, regulatory-bound devices is a key enabler of market acceleration.

What Market Pressures Are Shaping CDMO Engagement Strategies?

A highly competitive healthcare environment, shrinking product lifecycles, and increasing cost pressures are reshaping how OEMs engage with CDMOs. Outsourcing is no longer limited to cost-efficiency-it has become a strategic move to gain competitive advantage. CDMOs are now expected to offer integrated end-to-end services that span early design and prototyping, regulatory documentation, clinical trial support, and commercial-scale production. Moreover, with tightening regulatory frameworks by bodies such as the FDA, MDR (EU), and NMPA (China), CDMOs must ensure global compliance and traceability across the product life cycle. This regulatory complexity is pushing OEMs to seek CDMOs with established quality systems (such as ISO 13485 certification), in-house testing labs, and digital traceability platforms. Consolidation is also being witnessed within the CDMO space itself, with larger players acquiring niche technology firms to broaden capabilities across catheter and implantable verticals. This trend enables bundled service offerings, faster development timelines, and streamlined tech transfers-all critical factors for OEMs racing to commercialize next-gen medical devices.

The Growth In The Catheters And Active Implantable CDMO Market Is Driven By Several Factors……..

The growth in the catheters and active implantable CDMO market is driven by several factors rooted in device complexity, end-user needs, and strategic shifts within the MedTech industry. First, the rising prevalence of chronic conditions such as cardiovascular disease, neurological disorders, and diabetes is increasing demand for both diagnostic and therapeutic minimally invasive devices, expanding the need for catheter and implantable development. Second, hospitals and clinicians are increasingly favoring miniaturized, multifunctional devices that demand high levels of design intricacy and precision-capabilities typically concentrated within specialized CDMOs. Third, OEMs are offloading non-core operations such as manufacturing and regulatory submissions to CDMOs in order to focus on clinical innovation and market expansion. Furthermore, the medical device market’s push towards personalization-such as patient-specific catheter sizing or programmable implants-is increasing reliance on CDMOs with rapid prototyping and short-run manufacturing expertise. Geographic shifts in healthcare investments-particularly in Asia-Pacific, where governments are incentivizing local manufacturing-are also fueling regional CDMO expansions. Lastly, increased venture capital funding for MedTech startups is driving outsourcing from early development stages, creating sustained growth opportunities for CDMOs across the value chain.

SCOPE OF STUDY:

The report analyzes the Catheters and Active Implantable CDMO market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Service Category (Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices, Urology Implantable Devices); End-Use (Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use, Government Agencies End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • Abbott Laboratories
  • Alvimedica
  • Biomerics
  • Biotronik
  • Boston Scientific
  • Catalent
  • Cirtec Medical
  • Cochlear Limited
  • ConvaTec Group
  • Freudenberg Medical
  • Heraeus Group
  • Integer Holdings
  • LeMaitre Vascular
  • Medtronic
  • MicroPort
  • OrbusNeich
  • Recipharm
  • Smith & Nephew
  • Teleflex
  • Vetter Pharma

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP36484

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Catheters and Active Implantable CDMO - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Burden of Chronic Diseases Drives Demand for Specialized Catheter and Implant Production
    • Surge in Minimally Invasive Procedures Expands Outsourcing Opportunities for CDMOs
    • Technological Advancements in Catheter Design Accelerate Product Development Pipelines
    • Increasing Complexity of Implantable Devices Strengthens Business Case for Specialized CDMO Services
    • Regulatory Stringency Encourages OEMs to Leverage CDMO Regulatory Expertise
    • Demand for Drug-Eluting and Smart Catheters Drives Need for Advanced Manufacturing Capabilities
    • Rise in Aging Population Generates Demand for Cardiac and Neuromodulation Implants
    • Expansion of Wearable and Connected Medical Devices Boosts Demand for Micro-Precision CDMOs
    • CDMO Involvement in Early-Stage Product Design Drives Co-Innovation Opportunities
    • Shift Toward Value-Based Healthcare Expands Opportunities for Cost-Efficient CDMO Solutions
    • Development of Bioresorbable Implants Spurs Innovation in Materials and Coatings
    • Stringent IP and Quality Standards Highlight Importance of Full-Service CDMO Offerings
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Catheters and Active Implantable CDMO Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Catheters and Active Implantable CDMO by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Catheters and Active Implantable CDMO by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Catheters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Active Implantable Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Active Implantable Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Active Implantable Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Neuromodulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Neuromodulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Neuromodulation Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Heart Failure Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Heart Failure Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Heart Failure Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Urology Implantable Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Urology Implantable Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Urology Implantable Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Medical Device OEM Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Medical Device OEM Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Medical Device OEM Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Academic & Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Academic & Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Academic & Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Government Agencies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Government Agencies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Government Agencies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Catheters and Active Implantable CDMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030
  • JAPAN
    • Catheters and Active Implantable CDMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030
  • CHINA
    • Catheters and Active Implantable CDMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: China 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: China 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030
  • EUROPE
    • Catheters and Active Implantable CDMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Catheters and Active Implantable CDMO by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Catheters and Active Implantable CDMO by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030
  • FRANCE
    • Catheters and Active Implantable CDMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: France 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: France 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030
  • GERMANY
    • Catheters and Active Implantable CDMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Catheters and Active Implantable CDMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Spain 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Russia 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Catheters and Active Implantable CDMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Catheters and Active Implantable CDMO by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Catheters and Active Implantable CDMO by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Catheters and Active Implantable CDMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: Australia 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030
  • INDIA
    • Catheters and Active Implantable CDMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: India 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: India 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: South Korea 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Catheters and Active Implantable CDMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Catheters and Active Implantable CDMO by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Catheters and Active Implantable CDMO by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Argentina 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Brazil 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Mexico 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Catheters and Active Implantable CDMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Catheters and Active Implantable CDMO by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Catheters and Active Implantable CDMO by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: Iran 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: Israel 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: UAE 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030
  • AFRICA
    • Catheters and Active Implantable CDMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 214: Africa 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!